返回
Antengene Corporation Limited（06996.HK）價格
06996.HK 股價走勢圖
ANTENGENE-B (06996.HK)
Antengene Corporation Limited
HK$3.56
-2.19%
$-0.08
盤中： Jan 21, 14:03:11 HKT
關鍵數據
前收市價
$3.7
開盤價
$3.64
當日範圍
$3.54 - $3.68
52週區間
$0.69 - $8.16
交易量
1.7M
平均成交量
2.4M
每股盈餘 (TTM)
-0.40
股息收益率
--
市值
$2.1B
什麼是 ANTENGENE-B？
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 152 full-time employees. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The firm's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
